
Switching space...
Please wait while we prepare your workspace
Oncoinvent is a drug development company based in Oslo, Norway. Oncoinvent develops novel alpha-emitting radioactive cancer treatments. Oncoinvents lead product Radspherin is currently undergoing clinical testing for the treatment of peritoneal carcinomatosis, a common metastatic complication of colorectal and ovarian cancer.
FOUNDATION
YEAR
YEAR
EMPLOYEESN/A
AVERAGE AGEN/A